Search Medical Condition
Please enter condition
Please choose location from dropdown

Allergy Clinical Trials

A listing of Allergy medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (258) clinical trials

The main purpose of this study is to compare the safety, efficacy, and tolerability of a once-daily topical application of IDP-123 Lotion compared to the IDP-123 Vehicle Lotion in subjects with moderate to severe acne. Subjects must be at least 9 years of age or older and generally healthy. IDP-123 ...

Phase

Participants with atopic dermatitis and eczema conditions will be given a lotion to use over the course of 4 weeks. They will be asked to return to the clinic at weeks 2 and 4 where assessments will be done to see how effective the lotion is.

Phase N/A

A randomized, double-blind, placebo-controlled, multi-center study to assess the safety, tolerability and immunologic effects of HAL-MPE1 subcutaneous immunotherapy in adult and pediatric subjects with peanut allergy.

Phase

Children and adolescents with HDM allergic asthma are asked to participate in a research study being conducted by Cohen Children's Medical Center of New York.

Phase N/A

The primary objective for part A of the study is to characterize the safety and pharmacokinetics (PK) of dupilumab administered as a single dose in pediatric patients, 6 months to less than 6 years of age with severe atopic dermatitis (AD). The primary objective for part B of the study ...

Phase

Have you had moderate to severe atopic dermatitis for at least 1 year? A clinical trial designed to evaluate the safety and effectiveness of a new investigational medication under development for adult patients with moderate-to-severe atopic dermatitis is currently being conducted. All subjects will receive injections of trial medication every ...

Phase N/A

The OXFORAD™ Study for Atopic Dermatitis is examining an investigational drug to see how safe and effective it is when given to people like you who have eczema.

Phase N/A

A research study is evaluating an investigational medication for moderate to severe atopic dermatitis, also known as eczema.

Phase N/A

The purpose of this study is to evaluate the efficacy and safety of baricitinib in adult participants with moderate to severe atopic dermatitis.

Phase

A randomised, double-blind, placebo-controlled, phase 3 trial to evaluate the efficacy and safety of an injectable medication, tralokinumab, in combination with topical corticosteroids in subjects with moderate-to-severe atopic dermatitis who are candidates for systemic therapy.

Phase